← FDA DRUG APPROVALS

FDA NDA · NDA017668

TENUATE

Sponsor: SANOFI AVENTIS US

APPLICATION
NDA017668
TYPE
NDA
ORIGINAL APPROVAL
1975-03-20
LATEST ACTION
2007-12-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TENUATEDiscontinued
DIETHYLPROPION HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

2007-12-07Labeling · Supplement 1AP
1981-05-18Labeling · Supplement 10AP
1980-05-27Labeling · Supplement 9AP
1980-05-12Manufacturing (CMC) · Supplement 8 · standardAP
1979-11-02Manufacturing (CMC) · Supplement 7 · standardAP
1978-04-27Manufacturing (CMC) · Supplement 6 · standardAP
1976-09-24Manufacturing (CMC) · Supplement 3 · standardAP
1976-09-24Manufacturing (CMC) · Supplement 4 · standardAP
1976-03-10Manufacturing (CMC) · Supplement 2 · standardAP
1975-03-20Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →